August 16, 2018Open Access

Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines – Multi-country assessment

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Other than elevated narcolepsy IRs in the period after vaccination campaigns in Sweden, we did not find an association between AS03- or MF59-adjuvanted pH1N1 vaccines and narcolepsy in children or adults in the sites studied, although power to evaluate the AS03-adjuvanted Pandemrix brand vaccine was limited in our study.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Weibel et al. (Thu,) studied this question.

synapsesocial.com/papers/69dd67af7808b00a4799da16 https://doi.org/https://doi.org/10.1016/j.vaccine.2018.08.008

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The narcolepsy-pandemic influenza story: Can the truth ever be unraveled?2015 · 46 citations
2Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis2017 · 205 citations
3Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study2018 · 21 citations
4Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china2011 · 508 citations
5Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects2014 · 2,508 citations

Me gusta

Guardar

Ver artículo completo